← Back
$TRAW All transactions

Traws Pharma, Inc.

A

$ Value

$0

Shares

104,544

Price

$0

Filed

Apr 8

Insider

Name

Parker Charles Nolan

Title

Chief Financial Officer

CIK

0002125562

Roles

Officer

Transaction Details

Transaction Date

2026-03-08

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,544

Footnotes

Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis. | Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date. | Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date. | Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.

Filing Info

Accession No.

0002125562-26-000004

Form Type

4

Issuer CIK

0001130598

Parker Charles Nolan's History

Date Ticker Type Value
2026-03-08 TRAW A $0
2025-12-12 TRAW A $0
2025-12-12 TRAW A $0
2025-10-12 TRAW A $0

Other Insiders at TRAW (90d)

Insider Bought Sold Last
STOVER JACK E 2026-03-08
CAUTREELS WERNER 2026-03-08
Leaman John Harold 2026-03-08
Dukes Iain D.
Chief Executive Officer
2026-03-08
Shoemaker Mary Teresa 2026-03-08
Clarke Trafford 2026-03-08
Savchuk Nikolay
Chief Operating Officer
2026-03-08
Pauza Charles David
Chief Science Officer Virology
2026-03-08
Redfield Robert
Chief Medical Officer
2026-03-08
Parker Charles Nolan
Chief Financial Officer
2025-12-12